Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
Xencor, Inc.
Xencor, Inc.
MBrace Therapeutics
Novartis
Var2 Pharmaceuticals
NantCell, Inc.
AstraZeneca
Tempus AI
Massive Bio, Inc.
Travera Inc
A2 Biotherapeutics Inc.
Palleon Pharmaceuticals, Inc.
Novita Pharmaceuticals, Inc.
Apollomics Inc.
Eli Lilly and Company
ModeX Therapeutics, An OPKO Health Company
Tempus AI
PureTech
VitaMed Research LLC
DxTerity Diagnostics
ADC Therapeutics S.A.
HiberCell, Inc.
Aurigene Discovery Technologies Limited
pharmaand GmbH
Klus Pharma Inc.
Kineta Inc.
Blue Note Therapeutics
Faron Pharmaceuticals Ltd
MacroGenics
TScan Therapeutics, Inc.
MacroGenics
SpeciCare
Sichuan Huiyang Life Science and Technology Corporation
Amgen
Optimata Ltd.
Altor BioScience
Merck Sharp & Dohme LLC
INSYS Therapeutics Inc
Calando Pharmaceuticals
Altor BioScience
Eisai Inc.
Auron Healthcare GmbH
Envita Medical Center, Inc.
Pharmacyclics LLC.
Millennium Pharmaceuticals, Inc.
GammaCan